(1)
Golotyuk, V. V. Tumor Cells Mitotic Activity Marker Ki-67 in Assessing the Neoadjuvant Chemoradiotherapy Effectiveness in Patients With Rectal Cancer. Rep. of Morph. 2017, 21, 465-468.